Lansforsakringar Fondforvaltning AB publ Decreases Stock Position in UnitedHealth Group Incorporated $UNH

Key Points

• Lansforsakringar Fondforvaltning AB reduced its stake in UnitedHealth Group by 0.8%, holding 303,506 shares valued at approximately $158.96 million, making it the fund's 15th largest position.
• CEO Patrick Hugh Conway sold 589 shares of UnitedHealth stock for about $179,645, resulting in a 5.36% decrease in his ownership.
• Analysts have recently lowered their price targets for UnitedHealth Group, with Piper Sandler revising it from $353 to $317, while maintaining an "overweight" rating on the stock.

Lansforsakringar Fondforvaltning AB publ reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 0.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 303,506 shares of the healthcare conglomerate's stock after selling 2,415 shares during the quarter. UnitedHealth Group makes up 1.0% of Lansforsakringar Fondforvaltning AB publ's investment portfolio, making the stock its 15th largest position. Lansforsakringar Fondforvaltning AB publ's holdings in UnitedHealth Group were worth $158,961,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in UNH. Bayforest Capital Ltd increased its holdings in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd increased its holdings in UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after acquiring an additional 50 shares in the last quarter. Kapitalo Investimentos Ltda purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $41,000. Copia Wealth Management purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $42,000. Finally, IAG Wealth Partners LLC purchased a new stake in shares of UnitedHealth Group during the first quarter worth about $42,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on UNH. Cantor Fitzgerald reiterated an "overweight" rating and set a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday. Oppenheimer lowered their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a report on Wednesday, July 30th. Wolfe Research lowered their price target on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a report on Tuesday, May 20th. Piper Sandler lowered their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Finally, Baird R W downgraded shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. Fifteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $353.00.

UnitedHealth Group Trading Up 2.5%

UNH traded up $7.48 during trading on Friday, hitting $309.77. 12,018,847 shares of the company's stock were exchanged, compared to its average volume of 20,287,358. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The stock has a 50 day moving average price of $288.16 and a 200 day moving average price of $381.70. The firm has a market cap of $280.55 billion, a P/E ratio of 13.42, a price-to-earnings-growth ratio of 1.95 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter in the prior year, the firm earned $6.80 earnings per share. UnitedHealth Group's quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.9%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's payout ratio is currently 38.30%.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. This represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.28% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.